Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: An Overview

Patients with hepatocellular carcinoma (HCC) face a common type of cancer, which is amongst the most deadly types of cancer worldwide. The therapeutic options range from curative resection or ablation to loco regional therapies in palliative setting and last but not least, systemic treatment. The la...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Diederick J. van Doorn, Robert Bart Takkenberg, Heinz-Josef Klümpen
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	MDPI AG 2020-12-01
Цуврал:	Pharmaceuticals
Нөхцлүүд:	hepatocellular carcinoma (HCC), immunotherapy systemic therapy checkpoint inhibition outcome toxicity tolerability
Онлайн хандалт:	https://www.mdpi.com/1424-8247/14/1/3
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!